SCHEMBL18177848

SCHEMBL18177848

CCOc1c(Cl)cc(C(=O)NC(C)(C)C)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.53
ALDH1A1 P00352 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
RAB9A P51151 2/20 0.53
HPGD P15428 2/20 0.53
GAA P10253 2/20 0.53
NPC1 O15118 1/20 0.53
ABL1 P00519 1/20 0.53
MAPT P10636 1/20 0.53
RIN1 Q13671 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KDM4E B2RXH2 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
HSD17B10 Q99714 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21164502 0.88 ALDH1A1 (0.51) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL7565086 0.82 ALDH1A1 (0.49) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL18181887 0.82 ALDH1A1 (0.59) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL6293600 0.77 LMNA (0.55) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL1457769 0.76 PLAU (0.64) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL1707450 0.76 LMNA (0.58) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL18382537 0.76 PLK1 (0.67) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL570284 0.73 MEN1 (0.49) LMNAALDH1A1MEN1KMT2AHPGD
SCHEMBL1458773 0.73 MEN1 (0.75) LMNAALDH1A1MEN1KMT2ARAB9A
SCHEMBL9944170 0.73 KMT2A (0.64) LMNAALDH1A1MEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage WASE, NISHIKANT 2020-03-05 US disclosed
US-10351883-B2 Compounds for increasing lipid synthesis and storage NUTECH VENTURES (US) 2019-07-16 US disclosed
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage INVITROGEN CORPORATION 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160312253-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 LMNA 966/4885ALDH1A1 1121/4885MEN1 2824/4885
US-10351883-B2 Compounds for increasing lipid synthesis and storage FASN, LIPC, SREBF2 LMNA 966/4885ALDH1A1 1121/4885MEN1 2824/4885
US-20200071735-A1 Compounds for Increasing Lipid Synthesis and Storage FASN, LIPC, SREBF2 LMNA 966/4885ALDH1A1 1121/4885MEN1 2824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.